The size of the total ankle replacement market in Europe is expected to be worth USD 103 million by 2028 from USD 78.4 million in 2023, growing at a CAGR of 5.62% from 2023 to 2028.
The growing geriatric population across the European region and the increasing prevalence of osteoarthritis and rheumatoid arthritis are majorly driving the total ankle replacement market in Europe. According to the statistics published by Eurostat, an estimated 21.1% of the European population was aged above 65 years in 2022. With the increase in age, most of the senior population lost near mobile joints and sought treatment to improve the mobile in their hands and legs. End-stage osteoarthritis of the ankle is a major problem in elderly patients who suffer from complete loss of mobility and functional impairment. Ankle arthritis is another condition that results in improper functioning of the joint, severe pain, and reduced quality of life. This situation can be reduced by having total ankle replacement surgery. Therefore, gaining popularity and increase in the success rate of ankle replacement surgeries are contributing to the regional market growth.
The growing number of awareness programs among the European population through social media and television advertisements about the availability of ankle replacement products and the surgery procedure are further favoring the growth rate of the European market.
In addition, an increasing number of advancements in ankle replacement surgeries is boosting the growth rate of the European total ankle replacement market. Advances in implant design and manufacturing of different prostheses with different materials, such as cementless and metallic, help to demand the market's growth in coming years. Furthermore, the growing number of research and development activities for the manufacturing of novel products and devices, increasing number of product approvals, favorable reimbursement policies, and increasing support and investments from the European governments are propelling the total ankle replacement market in Europe.
On the other side, factors such as high costs associated with replacement surgery and post-surgery complications such as stiffness, ankle weakness, redness, instability, loosening of the artificial joint, blood vessel damage, high risk of infections, long time to heal surgery areas, and itching are hampering the total ankle replacement market growth in Europe. Furthermore, poor awareness regarding total ankle replacement surgeries, lack of reimbursement policies in some European countries, and lack of prostheses products are the factor that impedes total ankle replacement market growth in the European region.
This research report on the European total ankle replacement market has been segmented and sub-segmented into the following categories:
By Design:
Based on the design, the HINTEGRA total ankle replacement segment is anticipated to showcase the fastest CAGR among all the segments in the European market during the forecast period.
By Country:
Geographically, the European region accounted for the largest share of the worldwide market in 2022 and is expected to grow at a noteworthy CAGR during the forecast period. The UK market is predicted to account for the leading share of the European market during the forecast period owing to the rising availability of different types of prostates for ankle replacement. Factors such as the growing number of advancements in healthcare technology and increasing healthcare expenditure by the European population are contributing to the growth of the total ankle replacement market in the UK. In addition, increasing clinical centers for conducting trials for the prosthetic ankle, which are made of different materials, and checking for durability and capability of the products help the market demand in the region. Furthermore, the manufacturing of customized prostates for surgery by the key players and the increasing number of ankle placement surgery centers and hospitals in the UK are favoring regional market growth.
During the forecast period, the German total ankle replacement market is predicted to capture a considerable share of the European market and witness a healthy CAGR. Factors such as the growing number of ankle replacement specialists in Germany and the increasing number of athletes undergoing total ankle replacement due to issues in ankle areas (sports injuries) are propelling the German market growth. In Germany, most surgery is done for the upper ankle with an endoprosthesis. In addition, advanced 3-component ankle joint prostheses are used for the replacement, which has a long lifetime of 15 years. Such factors help the development of the ankle replacement market during the forecast period.
KEY MARKET PLAYERS:
Stryker Corporation, Zimmer Biomet Holdings, Inc., Integra LifeSciences Corporation, Wright Medical Group N.V. and MatOrtho Ltd are some of the notable companies in the European total ankle replacement market.
Frequently Asked Questions
The Europe total ankle replacement market is anticipated to grow at a CAGR of 5.62% from 2023 to 2028.
Stryker Corporation, Zimmer Biomet Holdings, Inc., Integra LifeSciences Corporation, Wright Medical Group N.V., and MatOrtho Ltd are some of the key players in the European total ankle replacement market.
The growing popularity of minimally invasive surgery techniques, the development of advanced implant materials, and the increasing demand for ankle replacement procedures among aging populations are some of the trends in the European total ankle replacement market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region